Bellevue Group AG
All holdings · as of Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Insulet Corp | $53.07M | 1.0% |
| Dexcom Inc | $56.24M | 1.1% |
| UNITEDHEALTH GROUP INC | $57.83M | 1.1% |
| IDEXX LABORATORIES INC /DE | $63.96M | 1.2% |
| Relay Therapeutics, Inc. | $70.60M | 1.3% |
| Medtronic plc | $73.64M | 1.4% |
| Vera Therapeutics, Inc. | $85.99M | 1.6% |
| Edwards Lifesciences Corp | $88.92M | 1.7% |
| IMMUNOCORE HOLDINGS PLC-ADRIMCR | $97.08M | 1.8% |
| Celldex Therapeutics, Inc. | $98.26M | 1.9% |
| Krystal Biotech, Inc. | $101.16M | 1.9% |
| Nuvalent, Inc. | $104.36M | 2.0% |
| STRYKER CORP | $126.73M | 2.4% |
| Viridian Therapeutics, Inc. | $135.64M | 2.6% |
| BOSTON SCIENTIFIC CORP | $148.71M | 2.8% |
| AMICUS THERAPEUTICS INC | $152.87M | 2.9% |
| ABBOTT LABORATORIES | $165.00M | 3.1% |
| Alnylam Pharmaceuticals Inc | $177.31M | 3.4% |
| Scholar Rock Holding Corp | $178.69M | 3.4% |
| Intuitive Surgical Inc | $182.38M | 3.5% |
| Avidity Biosciences, Inc. | $189.77M | 3.6% |
| NEUROCRINE BIOSCIENCES INC | $241.58M | 4.6% |
| VERTEX PHARMACEUTICALS INC / MA | $308.79M | 5.9% |
| IONIS PHARMACEUTICALS INC | $379.90M | 7.2% |
| ARGENX SE | $388.40M | 7.4% |
| Revolution Medicines, Inc. | $398.71M | 7.6% |